Mersana Therapeutics, Inc. revenue breakdown overview

Mersana Therapeutics, Inc. revenue for the last year amounted to 40.50 M USD, the most of which — 40.50 M USD — came from its highest performing source at the moment, Antibody-drug Conjugates, the year earlier bringing 36.85 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Mersana Therapeutics, Inc. 40.50 M USD, and the year before that — 36.85 M USD.